|  | Age (mean ± SD) | Mean follow-up (years) |  | Number of subjects | RR (95% CI) | ||||
---|---|---|---|---|---|---|---|---|---|---|
Grade | Study | Â | Â | Definition | HTN | NL | All dementia | VaD | AD + VaD | AD |
B1 | Yoshitake et al. 1995 [11]; Hisayama (n = 828) | 73.6 ± 5.9a | 7 | Per 1 SD increase (23 mmHg) |  |  |  | 1.6 (1.2, 2.2) b |  | 1.0 (0.7, 1.4)b |
B1 | Launer et al. 2000 [27]; HAAS (n = 3,734) | 52.7 ± 4.7 (men) | 27 | Untreated SBP ≥160 | 227 | 2,295 | 4.85 (1.99, 11.83) c | 10.68 (3.49, 32.64) c | 1.75 (0.58, 5.29)c | - |
 |  |  |  | Untreated DBP ≥90 | 132 | 1,128 | 4.32 (1.72, 10.85) c | 4.61 (1.61, 13.19) c | 2.78 (0.54, 14.25)c | 6.6 (2.0, 21.4) c |
B1 | Kivipelto et al. 2002 [35] (n = 2,293) | 50.2 ± 6.0 | 21 | SBP 140-159 | - | - | 1.9 (0.8, 4.8)d |  |  | 1.6 (0.7, 4.2)d |
 |  |  |  | SBP = 160 | - | - | 2.8 (1.1, 7.2) d |  |  | 2.6 (1.1, 7.2) d |
 |  |  |  | DBP 90-94 | - | - | 1.4 (0.5, 3.6)d |  |  | 1.2 (0.4, 3.3)d |
 |  |  |  | DBP ≥ 90 | - | - | 2.3 (1.1, 5.1) d |  |  | 2.0 (0.9, 4.6)d |
B1 | Qiu et al. 2010 [2]; Kungsholmen (n = 1,270) | 81.5 ± 5.0 | 5.1 | SBP 140-159 | 127 | 278 | 1.22 (0.89, 1.68)e |  |  | 1.47 (1.02, 2.12) e |
 |  |  |  | SBP ≥ 160 | 127 | 351 | 1.49 (0.94, 2.37)e |  |  | 1.84 (1.06, 3.18) e |
B1 | Rönnemaa et al. 2011 [3]; Uppsala (n = 2,268) | 49.6 ± 0.6 | 29 | Per 1 SD increase (18 mmHg) |  |  | 1.2 (1.0, 1.3) f | 1.3 (1.1, 1.6) f | 1.1 (1.0, 1.2) f | 1.0 (0.8, 1.2)f |
 |  | 71.0 ± 0.6 | 13 | Per 1 SD increase (19 mmHg) |  |  | 1.2 (1.0, 1.3) f | 1.6 (1.2, 2.1) f | 1.1 (1.0, 1.3) f | 1.0 (0.8, 1.2)f |
B2 | Shah et al. 2006 [28]; ROS (n = 824) | 75 ± 7 | 6.0 | Per 1 mmHg increase in SBP |  |  |  |  |  | 0.995 (0.986, 1.004)g |
 |  |  |  | Per 1 mmHg increase in SBP |  |  |  |  |  | 1.000 (0.985, 1.015)g |